☰

Drew J. Schwartz, Ph.D. - Publications

Affiliations: 
2015 Biology and Biomedical Sciences (Molecular Microbiology and Microbial Pathogenesis) Washington University, Saint Louis, St. Louis, MO 
Area:
Microbiology Biology, Cell Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Blake KS, Schwartz DJ, Paruthiyil S, Wang B, Ning J, Isidean SD, Burns DS, Whiteson H, Lalani T, Fraser JA, Connor P, Troth T, Porter CK, Tribble DR, Riddle MS, et al. Gut microbiome and antibiotic resistance effects during travelers' diarrhea treatment and prevention. Mbio. e0279023. PMID 38085102 DOI: 10.1128/mbio.02790-23  0.317
2023 Wilson NG, Hernandez-Leyva A, Schwartz DJ, Bacharier LB, Kau AL. The gut metagenome harbors metabolic and antibiotic resistance signatures of moderate-to-severe asthma. Biorxiv : the Preprint Server For Biology. PMID 36711684 DOI: 10.1101/2023.01.03.522677  0.602
2021 Langdon A, Schwartz DJ, Bulow C, Sun X, Hink T, Reske KA, Jones C, Burnham CD, Dubberke ER, Dantas G. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study. Genome Medicine. 13: 28. PMID 33593430 DOI: 10.1186/s13073-021-00843-9  0.406
2020 Schwartz DJ, Langdon AE, Dantas G. Understanding the impact of antibiotic perturbation on the human microbiome. Genome Medicine. 12: 82. PMID 32988391 DOI: 10.1186/s13073-020-00782-x  0.335
2019 Schwartz DJ, Rebeck ON, Dantas G. Complex interactions between the microbiome and cancer immune therapy. Critical Reviews in Clinical Laboratory Sciences. 1-19. PMID 31526274 DOI: 10.1080/10408363.2019.1660303  0.323
2019 Thänert R, Reske KA, Hink T, Wallace MA, Wang B, Schwartz DJ, Seiler S, Cass C, Burnham CA, Dubberke ER, Kwon JH, Dantas G. Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections. Mbio. 10. PMID 31455657 DOI: 10.1128/Mbio.01977-19  0.522
2019 Thanert R, Reske K, Hink T, Wallace M, Wang B, Schwartz D, Burnham C, Seiler S, Cass C, Dubberke ER, Dantas G, Kwon JH. 2847. Comparative Genomics and Clonal Tracking of Multi-drug-Resistant Uropathogens Implicates the Fecal Microbiome as a Potential Reservoir for Recurrent Urinary Tract Infections Open Forum Infectious Diseases. 6: S70-S71. DOI: 10.1093/Ofid/Ofz359.152  0.469
2018 Schwartz DJ, Elward A, Storch GA, Rosen DA. Ureaplasma urealyticum pyelonephritis presenting with progressive dysuria, renal failure, and neurologic symptoms in an immunocompromised patient. Transplant Infectious Disease : An Official Journal of the Transplantation Society. e13032. PMID 30472777 DOI: 10.1111/Tid.13032  0.361
2016 O'Brien VP, Hannan TJ, Yu L, Livny J, Roberson ED, Schwartz DJ, Souza S, Mendelsohn CL, Colonna M, Lewis AL, Hultgren SJ. A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease. Nature Microbiology. 2: 16196. PMID 27798558 DOI: 10.1038/Nmicrobiol.2016.196  0.729
2015 Goneau LW, Hannan TJ, MacPhee RA, Schwartz DJ, Macklaim JM, Gloor GB, Razvi H, Reid G, Hultgren SJ, Burton JP. Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity. Mbio. 6. PMID 25827417 DOI: 10.1128/Mbio.00356-15  0.717
2015 Schwartz DJ, Conover MS, Hannan TJ, Hultgren SJ. Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection. Plos Pathogens. 11: e1004599. PMID 25569799 DOI: 10.1371/Journal.Ppat.1004599  0.707
2014 Hannan TJ, Roberts PL, Riehl TE, van der Post S, Binkley JM, Schwartz DJ, Miyoshi H, Mack M, Schwendener RA, Hooton TM, Stappenbeck TS, Hansson GC, Stenson WF, Colonna M, Stapleton AE, et al. Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis. Ebiomedicine. 1: 46-57. PMID 26125048 DOI: 10.1016/J.Ebiom.2014.10.011  0.709
2014 Kline KA, Schwartz DJ, Gilbert NM, Lewis AL. Impact of host age and parity on susceptibility to severe urinary tract infection in a murine model. Plos One. 9: e97798. PMID 24835885 DOI: 10.1371/Journal.Pone.0097798  0.507
2013 Schwartz DJ, Kalas V, Pinkner JS, Chen SL, Spaulding CN, Dodson KW, Hultgren SJ. Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proceedings of the National Academy of Sciences of the United States of America. 110: 15530-7. PMID 24003161 DOI: 10.1073/Pnas.1315203110  0.576
2012 Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL. Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infection and Immunity. 80: 4186-94. PMID 22988014 DOI: 10.1128/Iai.00684-12  0.648
2011 Schwartz DJ, Chen SL, Hultgren SJ, Seed PC. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection. Infection and Immunity. 79: 4250-9. PMID 21807904 DOI: 10.1128/Iai.05339-11  0.68
2011 Kline KA, Schwartz DJ, Lewis WG, Hultgren SJ, Lewis AL. Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection. Infection and Immunity. 79: 3588-95. PMID 21690238 DOI: 10.1128/Iai.00122-11  0.599
Show low-probability matches.